Unveiling the therapeutic role of Vibrio alginolyticus GH5 exopolysaccharide in Alzheimer's disease.

Fuente: PubMed
Guardado en:
Detalles Bibliográficos
Autores principales: Abdelrazik, Mohamad, El Awady, Mohamed E, Abdel-Razik, Ghada, Rashad, Alaa, Ali, Mohamed, Eltaher, Ashraf, Hamed, Ahmed A
Formato: Artículo científico
Lenguaje:en
Publicado: International journal of biological macromolecules 2025
Materias:
Acceso en línea:
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1868266211750445057
author Abdelrazik, Mohamad
El Awady, Mohamed E
Abdel-Razik, Ghada
Rashad, Alaa
Ali, Mohamed
Eltaher, Ashraf
Hamed, Ahmed A
author_facet Abdelrazik, Mohamad
El Awady, Mohamed E
Abdel-Razik, Ghada
Rashad, Alaa
Ali, Mohamed
Eltaher, Ashraf
Hamed, Ahmed A
Abdelrazik, Mohamad
El Awady, Mohamed E
Abdel-Razik, Ghada
Rashad, Alaa
Ali, Mohamed
Eltaher, Ashraf
Hamed, Ahmed A
collection PubMed - marine biology
contents Unveiling the therapeutic role of Vibrio alginolyticus GH5 exopolysaccharide in Alzheimer's disease. Abdelrazik, Mohamad El Awady, Mohamed E Abdel-Razik, Ghada Rashad, Alaa Ali, Mohamed Eltaher, Ashraf Hamed, Ahmed A Animals Vibrio alginolyticus Mice Polysaccharides, Bacterial Alzheimer Disease Rats RAW 264.7 Cells Male Antioxidants Cell Survival Vibrio alginolyticus strain GH5 (OR865148.1) was isolated from the Red Sea, Hurghada, Egypt, and classified according to cultural attributes, biochemical properties, and the analysis of genetic relationships using 16S rRNA sequences. A substantial proportion of exopolysaccharides (EPS) in GH5-EPS contained a sulfate level of 19.8 %, uronic acid of 6.7 %, and N-acetylglucosamine of 16.07 %. The composition of monosaccharides in these fractions consists of arabinose, glucose, and galacturonic acid in a proportion of 2:1:2, respectively. GH5-EPS surface appeared as a needle-like shape by SEM. GH5-EPS enhancement of the RAW264.7 macrophage line ATTC number J774 cell proliferation via MTT assay for cell viability. GH5-EPS had a high immunomodulatory effect on releasing TNF-alfa and IL-10. Followed by its effect against cyclooxygenase (COX-2) and lipoxygenase (LOX). Antioxidant activity was evaluated for GPx4, GSS, and MDA with highly significant results for DPPH, ABTS, and iron chelating. AChE was inhibited by a mean of (30.25 ± 1.76 and 52.1 ± 2.77 μg/mL). GH5-EPS illustrated a good treatment effect for AD in a rat animal model, supporting biochemical studies, histopathology for some brain parts, and toxicity. Bioinformatic investigation for GH5 gene and translated protein structure and function provide insights for future drug-targeting of the EPS production pathway.
format Artículo científico
id pubmed_40294669
institution PubMed
language en
publishDate 2025
publisher International journal of biological macromolecules
record_format pubmed
spellingShingle Unveiling the therapeutic role of Vibrio alginolyticus GH5 exopolysaccharide in Alzheimer's disease.
Abdelrazik, Mohamad
El Awady, Mohamed E
Abdel-Razik, Ghada
Rashad, Alaa
Ali, Mohamed
Eltaher, Ashraf
Hamed, Ahmed A
Animals
Vibrio alginolyticus
Mice
Polysaccharides, Bacterial
Alzheimer Disease
Rats
RAW 264.7 Cells
Male
Antioxidants
Cell Survival
Unveiling the therapeutic role of Vibrio alginolyticus GH5 exopolysaccharide in Alzheimer's disease. Abdelrazik, Mohamad El Awady, Mohamed E Abdel-Razik, Ghada Rashad, Alaa Ali, Mohamed Eltaher, Ashraf Hamed, Ahmed A Animals Vibrio alginolyticus Mice Polysaccharides, Bacterial Alzheimer Disease Rats RAW 264.7 Cells Male Antioxidants Cell Survival Vibrio alginolyticus strain GH5 (OR865148.1) was isolated from the Red Sea, Hurghada, Egypt, and classified according to cultural attributes, biochemical properties, and the analysis of genetic relationships using 16S rRNA sequences. A substantial proportion of exopolysaccharides (EPS) in GH5-EPS contained a sulfate level of 19.8 %, uronic acid of 6.7 %, and N-acetylglucosamine of 16.07 %. The composition of monosaccharides in these fractions consists of arabinose, glucose, and galacturonic acid in a proportion of 2:1:2, respectively. GH5-EPS surface appeared as a needle-like shape by SEM. GH5-EPS enhancement of the RAW264.7 macrophage line ATTC number J774 cell proliferation via MTT assay for cell viability. GH5-EPS had a high immunomodulatory effect on releasing TNF-alfa and IL-10. Followed by its effect against cyclooxygenase (COX-2) and lipoxygenase (LOX). Antioxidant activity was evaluated for GPx4, GSS, and MDA with highly significant results for DPPH, ABTS, and iron chelating. AChE was inhibited by a mean of (30.25 ± 1.76 and 52.1 ± 2.77 μg/mL). GH5-EPS illustrated a good treatment effect for AD in a rat animal model, supporting biochemical studies, histopathology for some brain parts, and toxicity. Bioinformatic investigation for GH5 gene and translated protein structure and function provide insights for future drug-targeting of the EPS production pathway.
title Unveiling the therapeutic role of Vibrio alginolyticus GH5 exopolysaccharide in Alzheimer's disease.
topic Animals
Vibrio alginolyticus
Mice
Polysaccharides, Bacterial
Alzheimer Disease
Rats
RAW 264.7 Cells
Male
Antioxidants
Cell Survival
url https://pubmed.ncbi.nlm.nih.gov/40294669/